GRAPHIC: UMass Medical School logo (6kb) Header Graphic
 
spacer graphic

Section: Research

John Landers, Ph.D.

Academic Role: Associate Professor

Faculty Appointment(s) In:
   Neurology

Other Affiliation(s):
   Program in Neuroscience

Research Description:

Genetics of Familial and Sporadic ALS

Landers

Amyotrophic lateral sclerosis (ALS) is a uniformly lethal, age-dependent neurodegenerative disorder with a typical survival of 2 to 5 years. Our laboratory is focused on using high-throughput genomic technologies to identify the genes involved in the development of sporadic and familial ALS. Most recently, our lab has utilized high-density SNP arrays to analyze over 300,000 DNA polymorphisms within ~4,000 subjects to test for their association to sporadic ALS. Through our efforts, we have identified KIFAP3, a kinesin II complex member responsible for fast anterograde axonal transport, as a modifier of survival in sporadic ALS. Homozygotes for the favorable allele located in the promoter region of KIFAP3 display a survival advantage of 14.0 months, a substantial increment (~30%) in this disease. Currently, our efforts are focused on understanding how KIFAP3 influences survival and how we can use this information to aid in the development of strategies to extend the lifespan of ALS patients.

 


Office: LRB 604
Phone: 508-856-6221
E-mail: John.Landers@umassmed.edu
Keywords: Genomics, ALS, Motor Neuron Disease, Medical Genetics, Genetics

More on John Landers' Research
Research | Publications | Rotations | Biography
View All Sections on One Page

spacer graphic
INTRANET spacer graphic top   print   spacer graphic